News
Bliss GVS Pharma consolidated net profit rises 12.32% in the September 2025 quarter
07-Nov-2025 | 07:43
Sales rise 12.27% to Rs 244.40 crore
Net profit of Bliss GVS Pharma rose 12.32% to Rs 27.25 crore in the quarter ended September 2025 as against Rs 24.26 crore during the previous quarter ended September 2024. Sales rose 12.27% to Rs 244.40 crore in the quarter ended September 2025 as against Rs 217.68 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 244.40 | 217.68 | 12 |
| OPM % | 13.00 | 19.05 | - |
| PBDT | 48.89 | 42.69 | 15 |
| PBT | 40.63 | 35.71 | 14 |
| NP | 27.25 | 24.26 | 12 |
Powered by Capital Market - Live News